{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["27(9)"],"submitter":["Tartaglia D"],"funding":["Università di Pisa"],"pubmed_abstract":["<h4>Background</h4>Immunocompromised patients with acute diverticulitis are at increased risk of morbidity and mortality. The aim of this study was to compare clinical presentations, types of treatment, and outcomes between immunocompromised and immunocompetent patients with acute diverticulitis.<h4>Methods</h4>We compared the data of patients with acute diverticulitis extracted from the Web-based International Registry of Emergency Surgery and Trauma (WIRES-T) from January 2018 to December 2021. First, two groups were identified: medical therapy (A) and surgical therapy (B). Each group was divided into three subgroups: nonimmunocompromised (grade 0), mildly to moderately (grade 1), and severely immunocompromised (grade 2).<h4>Results</h4>Data from 482 patients were analyzed-229 patients ("],"journal":["Techniques in coloproctology"],"pagination":["747-757"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10404182"],"repository":["biostudies-literature"],"pubmed_title":["Acute diverticulitis in immunocompromised patients: evidence from an international multicenter observational registry (Web-based International Register of Emergency Surgery and Trauma, Wires-T)."],"pmcid":["PMC10404182"],"pubmed_authors":["Zakaria AD","Ghannam W","Scalzone R","Marin PAG","Podda M","Ioannidis O","Tochie JN","Cillara N","Caicedo Y","Osipov A","Elisa NG","Elbahnasawy M","Litvin A","Costa G","Gubbiotti F","Yanez C","Zese M","Patel T","Sartelli M","Chirica M","Corte H","Kara Y","Isik A","Gelmini R","Goksoy B","Luppi D","Marcela L","Zizzo M","Nikolopoulos I","Vailas M","Mulita F","Chiarugi M","Yovtchev Y","Negoi I","Fonseca VC","Perrone S","Paratore F","Altintoprak F","Zaghi C","WIRES-T for Acute Diverticulitis Study Group","Coccolini F","Tomadze G","Parini D","Brisinda G","Doklestic LAK","Lostoridis E","Fugazzola P","Loncar Z","Cremonini C","Pappalardo V","Garzali IU","Strambi S","Dimitrov E","Seretis C","Kuptsov A","Garcia FH","Chowdhury S","Ahmed AYYM","Salvetti F","Occhionorelli S","Toma EA","Sydorchuk R","Nardi M","Tartaglia D","Kirkpatrick AW","Uzunoglu MY","Sibilla MG","Benedetti F","D'Agostino F","Omerovic M","Ntentas I","Yalkin O","Romeo L","Scaramuzzo R","Sotiropoulou M","Musetti S","Manatakis D","Annunziata E","Bellanova G","Ceresoli M","Muratore A","Balalis D","Perivoliotis K","Catena F","Bala M","Gambino G","Muhtaroglu A","Lunghi EG","Lesevic I","Micic D","Cui Y","Hadzhiev D","Martines G","Ugoletti L"],"additional_accession":[]},"is_claimable":false,"name":"Acute diverticulitis in immunocompromised patients: evidence from an international multicenter observational registry (Web-based International Register of Emergency Surgery and Trauma, Wires-T).","description":"<h4>Background</h4>Immunocompromised patients with acute diverticulitis are at increased risk of morbidity and mortality. The aim of this study was to compare clinical presentations, types of treatment, and outcomes between immunocompromised and immunocompetent patients with acute diverticulitis.<h4>Methods</h4>We compared the data of patients with acute diverticulitis extracted from the Web-based International Registry of Emergency Surgery and Trauma (WIRES-T) from January 2018 to December 2021. First, two groups were identified: medical therapy (A) and surgical therapy (B). Each group was divided into three subgroups: nonimmunocompromised (grade 0), mildly to moderately (grade 1), and severely immunocompromised (grade 2).<h4>Results</h4>Data from 482 patients were analyzed-229 patients (","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Sep","modification":"2025-04-04T19:28:07.853Z","creation":"2025-02-19T04:01:02.185Z"},"accession":"S-EPMC10404182","cross_references":{"pubmed":["36749438"],"doi":["10.1007/s10151-023-02758-6"]}}